EnBiGen: Endophenotype Characterization of a Family Psychiatric Disorder

Sponsor
University Hospital, Grenoble (Other)
Overall Status
Unknown status
CT.gov ID
NCT02843997
Collaborator
(none)
29
1
1
36
0.8

Study Details

Study Description

Brief Summary

Bipolar disorder is a chronic and frequent mood pathology, that impacts on emotional and socio-professional life of sick subjects, and also increase mortality by suicide. Suicide is considered as a bipolar disorder result.

The main goal of this study is the endophenotype characterization from a clinical and cognitive point of view, of a bipolar spectrum's disorder present in a family, and then highlight a mutation of one of the genes involved is this disorder.

Condition or Disease Intervention/Treatment Phase
  • Genetic: Endophenotype and sequencing
N/A

Detailed Description

Heritability of bipolar disorder is now well established, but seems to be multifactorial in most of the cases.

The use of an endophenotype characterized in a family presenting numerous bipolar sufferers enable to reflect the expression of simpler genetic variants than those involved in the disease, and might enable the identification of genes involved in the etiopathogenesis of this endophenotype.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
29 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Official Title:
Endophenotype Characterization of a Family Psychiatric Disorder of the Bipolar Spectrum, With an Autosomal Dominant Expression
Study Start Date :
Feb 1, 2015
Anticipated Primary Completion Date :
Feb 1, 2018
Anticipated Study Completion Date :
Feb 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Other: Healthy volunteers

Members of a family

Genetic: Endophenotype and sequencing
Draw an endophenotype and genetic study

Outcome Measures

Primary Outcome Measures

  1. Neuropsychological evaluations tests [One day]

    Neuropsychological evaluations (about one hour) : TMT (Trail Making Test) A and B, Stroop VFT (Visual Field Testing), DST (Dyslexia Screening Test) Tower of London test Hayling, CPT (continuous performance task) CVLT (California Verbal Learning Test) tests.

  2. Eye tracking. [One hour]

    The volunteer will follow an instruction according to the color seen on a screen. This instruction is to look at the side where there is a flashlight and to look at the opopsite if the light is unbroken. Mistakes will be count.

  3. Blood sampling [3 minutes]

    Genetic sample for extraction of DNA.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Members of a family adult (more than 18 years)

  • Signed informed consents

  • Registered to a French social security or possesor of the European Health Insurance Card

Exclusion Criteria:
Clinical part :
  • Refusal to sign the participation study consent.

  • Organic affection likely to affect cognitive abilities and brain structures or acute decompensation of a bipolar disorder.

Genetic part :
  • Refusal to sign the genetic sample consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 UniversityHospitalGrenoble La Tronche France 38700

Sponsors and Collaborators

  • University Hospital, Grenoble

Investigators

  • Principal Investigator: Jérôme Holtzmann, Doctor, Grenoble Hospital University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University Hospital, Grenoble
ClinicalTrials.gov Identifier:
NCT02843997
Other Study ID Numbers:
  • 38RC14.321
First Posted:
Jul 26, 2016
Last Update Posted:
Jul 26, 2016
Last Verified:
Jul 1, 2016
Keywords provided by University Hospital, Grenoble
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 26, 2016